Continuing decreases in asthma mortality in the United States

Annals of Allergy, Asthma and Immunology

Volumn 92, Issue 3, 2004, Pages 313-318

  Sly, R Michael ^a,b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; ARTICLE; ASTHMA; CAUSE OF DEATH; FEMALE; HUMAN; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RACE; UNITED STATES;

EID: 1642285942     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61568-2     Document Type: Article

References (50)

1. US Department of Health, Education, and Welfare. Vital Statistics of the United States, 1950-60. Washington, DC: US Dept of Health, Education, and Welfare; 1954-1960.
2. Sly RM. Increases in deaths from asthma. Ann Allergy. 1984;53:20-25.
3. Sly RM, O'Donnell R. Stabilization of asthma mortality. Ann Allergy Asthma Immunol. 1997;78:347-354.
4. Sly RM. Decreases in asthma mortality in the United States. Ann Allergy Asthma Immunol. 2000;85:121-127.
5. Klebba AJ, Scott JH. Estimates of selected comparability ratios based on dual coding of 1976 death certificates by the eighth and ninth revisions of the International Classification of Diseases. Hyattsville, MD: National Center for Health Statistics; 1980. DHEW publication PHS 80-1120.
6. Murphy SL. Deaths: final data for 1998. Natl Vital Stat Rep. 2000;48:1-105.
7. Hoyert DL, Arias E, Smith BL, et al. Deaths: final data for 1999. Natl Vital Stat Rep. 2001:49:1-113.
8. Minino AM, Arias E, Kochanek KD, et al. Deaths: final data for 2000. Natl Vital Stat Rep. 2002;50:1-119
9. US Department of Health, Education and Welfare. Vital Statistics of the United States - 1980, Vol II, Mortality, Part A, Section 7. Washington, DC: US Dept Health, Education and Welfare; 1985:16.
10. Anderson RN, Rosenberg HM. Age standardization of death rates: implementation of the year 2000 standard. Natl Vital Stat Rep. 1998;47:1-16, 20.
11. Anderson RN, Miniaeo AM, Hoyert DL, Rosenberg HM. Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. Natl Vital Stat Rep. 2001;49:1-38.
12. Jackson RT, Beaglehole R, Rea HH, Sutherland DC. Mortality from asthma: a new epidemic in New Zealand. BMJ. 1982;285:771-774.
13. British Thoracic Society. Accuracy of death certificates in bronchial asthma. Thorax. 1984;39:505-509.
14. Stewart CJ, Nunn AJ. Are asthma mortality rates changing? Br J Dis Chest. 1985;79:229-234.
15. Sly RM. Mortality from asthma, 1979-1984. J Allergy Clin Immunol. 1988;82:705-717.
16. Vollmer WM, Osborne ML, Buist AS. Uses and limitations of mortality and health care utilization statistics in asthma research. Am J Respir Crit Care Med. 1994;149:579-587.
17. Sly RM. Changing asthma mortality. Ann Allergy. 1994;73:259-268.
18. Sly RM. Mortality from asthma in children 1979-1984. Ann Allergy. 1988;60:433-443.
19. Mannino DM, Homa DM, Akinbami LJ, et al. Surveillance for asthma-United States, 1980-1999. MMWR Surveil Summ. 2002;51:1-13.
20. Sly RM. Optimal management improves asthma morbidity and mortality. Ann Allergy Asthma Immunol. 2003;90:10-12.
21. Schwartz J, Cold D, Dockery DW, et al. Predictors of asthma and persistent wheeze in a national sample of children in the United States. Am Rev Respir Dis. 1990;142:555-562.
22. Sporik R, Holgate ST, Platts-Mills TA, et al. Exposure to house dust mite allergen (Der p I) and the development of asthma in childhood. N Engl J Med. 1990;323:502-507.
23. Weitzman M, Gortmaker S, Sobol A. Racial, social, and environmental risks for childhood asthma. Am J Dis Child. 1990;144:1189-1194.
24. Arshad SH, Stevens M, Hide DW. The effect of genetic and environmental factors on the prevalence of allergic disorders at the age of two years. Clin Exp Allergy. 1993;23:504-511.
25. Infante-Rivard C. Childhood asthma and indoor environmental risk factors. Am J Epidemiol. 1993;137:834-844.
26. Sly RM. Changing prevalence of allergic rhinitis and asthma. Ann Allergy Asthma Immunol. 1999;82:233-252.
27. Carr W, Zeitel L, Weiss K. Variations in asthma hospitalizations and deaths in New York City. Am J Public Health. 1992;82:59-65.
28. Lang DM, Polansky M. Patterns of asthma mortality in Philadelphia from 1969-1991. N Engl J Med. 1994;331:1542-1546.
29. Strunk RC, Mrazek DA, Fuhrmann GS, LeBrecque JF. Physiologic and psychological characteristics associated with deaths due to asthma in childhood. JAMA. 1985;254:1193-1198.
30. Rea HH, Scragg R, Jackson R, et al. A case control study of deaths from asthma. Thorax. 1986;41:833-839.
31. Sears MR, Rea HH, Beaglehole R, et al. Asthma mortality in New Zealand: a two year national study. NZ Med J. 1985;98:271-275.
32. Rea HH, Sears MR, Beaglehole R, et al. Lessons from the national asthma mortality study: circumstances surrounding death. NZ Med J. 1987;100:10-13.
33. Robertson CF, Rubinfeld AR, Bowes G. Deaths from asthma in Victoria: a 12-month survey. Med J Aust. 1990;152:511-517.
34. O'Hollaren MT, Yunginger JW, Offord KP, et al. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med. 1991;324:359-363.
35. Joseph KS, Blais L, Ernst P, Suissa S. Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquilisers. BMJ. 1996;312:79-83.
36. Levenson T, Greenberger PA, Donoghue ER, Lifschultz BD. Asthma deaths confounded by substance abuse: an assessment of fatal asthma. Chest. 1996;110:604-610.
37. Guite HF, Dundas R, Burney PG. Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma. Thorax. 1999;54:301-307.
38. Hessel PA, Mitchell I, Tough S, et al. Risk factors for death from asthma. Ann Allergy Asthma Immunol. 1999;83:362-368.
39. Yao T-C, Kuo M-L, See L-C, et al. The RANTES promotor polymorphism: a genetic risk factor for near-fatal asthma in Chinese children. J Allergy Clin Immunol. 2003;111:1285-1292.
40. 2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest. 1997;100:3184-3188.
41. 2-adrenergic receptor on albuterol bronchodilator pharmacodynamics. Clin Pharmacol Ther. 1999;65:519-525.
42. 2 adrenoceptor polymorphism. Thorax. 2000;55:762-767.
43. Keating G, Mitchell EA, Jackson R, et al. Trends in sales of drugs for asthma in New Zealand, Australia, and the United Kingdom, 1975-81. BMJ. 1984;289:348-351.
44. Haas JF, Staudinger HW, Schuijt C. Asthma deaths in New Zealand [letter]. BMJ. 1992;304:1634.
45. Wilson JW, Jenkins CR. Asthma mortality: where is it going? Med J Aust. 1996;164:391-393.
46. Comino EJ, Mitchell CA, Bauman A, et al. Asthma management in eastern Australia, 1990 and 1993. Med J Aust. 1996;164:403-406.
47. National Heart, Lung, and Blood Institute. National Asthma Education Program Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: US Dept of Health and Human Services; August 1991. Publication 91-3042.
48. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: US Dept of Health and Human Services; April 1997. Publication 97-4051.
49. Sly RM. Changing asthma mortality and sales of inhaled bronchodilators and anti-asthmatic drugs. Ann Allergy. 1994;73:439-443.
50. Stafford RS, Ma J, Finkelstein SN, et al. National trends in asthma visits and asthma pharmacotherapy, 1978-2002. J Allergy Clin Immunol. 2003;111:729-735.